Decreased Exacerbations and Improvement in Asthma Symptom Control in Asthma COPD Overlap Treated With Omalizumab: Data From the Prospero Cohort Study

被引：2
|
作者：
Hanania, Nicola [1 ]
Chipps, Bradley [1 ]
Griffin, Noelle [1 ]
Trzaskoma, Benjamin [1 ]
Iqbal, Ahmar [1 ]
Casale, Thomas [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CHEST | 2017年 / 152卷 / 04期
关键词：
D O I：
10.1016/j.chest.2017.08.807
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：776A / 776A
页数：1
相关论文
共 50 条
  • [1] Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO
    Hanania, Nicola A.
    Chipps, Bradley E.
    Griffin, Noelle M.
    Yoo, Bongin
    Iqbal, Ahmar
    Casale, Thomas B.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (04) : 1629 - +
  • [2] Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal
    Sousa, A. S.
    Pereira, A. M.
    Fonseca, J. A.
    Azevedo, L. F.
    Abreu, C.
    Arrobas, A.
    Calvo, T.
    Silvestre, M. J.
    Cunha, L.
    Falcao, H.
    Drummond, M.
    Geraldes, L.
    Loureiro, C.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (06) : 327 - 333
  • [3] Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab)
    Chipps, Bradley W.
    Busse, William
    Luskin, Allan T.
    Zeiger, Robert S.
    Trzaskoma, Benjamin L.
    Griffin, Noelle M.
    Antonova, Evgeniya
    Limb, Susan L.
    Casale, Thomas B.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB8 - AB8
  • [4] Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use with Omalizumab from the Real-World PROSPERO Study
    Casale, Thomas B.
    Iqbal, Ahmar
    Dang, Joseph
    Yang, Ming
    Rajput, Yamina
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB99 - AB99
  • [5] Treatment Response To Omalizumab And Reduced Asthma Exacerbations And Asthma-Related Healthcare Resource Use From The Real-World PROSPERO Study
    Luskin, Allan
    Rajput, Yaminah
    Haselkorn, Tmirah
    Yang, Ming
    Dang, Joseph
    Chipps, Bradley
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB21 - AB21
  • [6] Impact of Baseline IgE levels on Exacerbations and Asthma Symptom Control After Omalizumab Initiation
    Casale, Thomas B.
    Gonzalez-Reyes, Erika G.
    Yang, Ming
    Trzaskoma, Benjamin L.
    Griffin, Noelle M.
    Chipps, Bradley E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB195 - AB195
  • [7] Exacerbations and hospitalizations due to exacerbations in asthma-COPD overlap sindrome (ACOS) in PUMA study
    De Oca, Maria Montes
    Varela, Maria Victorina Lopez
    Contreras, Maria Eugenia Laucho
    Casas, Alejandro
    Schiavi, Eduardo
    Mora, Juan Carlos
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [8] The Prevalence and Symptom Profile of Asthma-COPD Overlap: The HUNT Study
    Henriksen, Anne H.
    Langhammer, Arnulf
    Steinshamn, Sigurd
    Mai, Xiao-Mei
    Brumpton, Ben M.
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 15 (01) : 27 - 35
  • [9] The prevalence and symptom profile of asthma-COPD overlap: The HUNT Study
    Brumpton, Ben
    Langhammer, Arnulf
    Mai, Xiao-Mei
    Steinshamn, Sigurd
    Henriksen, Anne Hildur
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study
    Pereira, Sophie
    Bautin, Nathalie
    Verhille, Juliette
    Bonniaud, Philippe
    Devouassoux, Gilles
    Fry, Stephanie
    Guilleminault, Laurent
    Khayath, Naji
    Leroyer, Christophe
    Chenivesse, Cecile
    Bautin, Nathalie
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345